Since its creation in 2004, ECDC has been committed to protecting human health through the prevention and control of communicable diseases and special health issues.
OJ/2023/DPR/26575 - External quality assessment of antimicrobial susceptibility testing for Salmonella and Campylobacter - Lot 1: AST EQA for Salmonella enterica - Lot 2: AST EQA for Campylobacter spp.
Ref.:OJ/2023/DPR/26575 - ECDC/2024/OP/0004 | Media type:call for tender
This document sets out the overall programme priorities for 2021–2027, setting them in the context in which ECDC operates and the changes and challenges that will affect communicable diseases in the EU/EEA Member States over that period.